Beulah

P.

Sabundayo

,

PharmD

Since coming to the Center for Immunization Research in 2008, my interests are primarily in program development, implementation, and management for early stage human vaccine trials. I have focused particularly on vaccines for flaviviruses (dengue virus, Zika virus and West Nile virus), but have also been involved in trials of vaccines against influenza, respiratory syncytial virus, Ebola and malaria. Of late, I have been involved in our COVID-19 vaccine trials. I provide training and oversight for members of the flavivirus vaccine team, and, in working with Dr. Durbin, have advanced our dengue virus vaccine from the earliest phase I studies through to phase 2 and 3 evaluation in dengue-endemic settings in Brazil and Viet Nam. As a Pharmacist I provide consultation on vaccine studies throughout the CIR, act as a liaison to the Investigational Drug Services, and standardize treatment algorithms such as anaphylaxis management. In addition, I have managed our Regulatory Compliance Team, which is responsible for communication with IRBs, FDA, Study Sponsors, and other regulatory bodies. In 2002, I founded the Johns Hopkins Hospital Moore Clinic’s Pharmacotherapy Clinic, later part of the Bartlett Service, that continues to thrive today, providing HIV care.